I agree that this site is using cookies. You can find further informations here.
X
Willenbacher, W.
83  results:
Search for persons X
?
1

Deep learning analysis of mid‐infrared microscopic imaging ..:

Zelger, P. ; Brunner, A. ; Zelger, B....
Journal of Biophotonics.  16 (2023)  11 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
2

Visible- and near-infrared hyperspectral imaging for the qu..:

Brunner, A. ; Willenbacher, E. ; Willenbacher, W....
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.  285 (2023)  - p. 121940 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P09: ATTRITION RATES IN MULTIPLE MYELOMA UNDER REAL WORLD C..:

Benda, MA ; Ulmer, H ; Weger, R...
HemaSphere.  6 (2022)  - p. 15-16 , 2022
Link: https://doi.org/10.1097/..
 
?
4

S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, ..:

Ludwig, H. ; Melchardt, T. ; Sormann, S....
HemaSphere.  6 (2022)  - p. 80-81 , 2022
Link: https://doi.org/10.1097/..
 
?
5

NIVOLUMAB FOR RELAPSED OR REFRACTORY (R/R) CLASSICAL HODGKI..:

Ansell, S. M. ; Bröckelmann, P. J. ; von Keudell, G....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
6

Real world analysis of high-cut-off (HCO) hemodialysis with..:

Steiner, N. ; Abdel Hamid, A. ; Kronbichler, A....
Journal of Nephrology.  34 (2020)  4 - p. 1263-1270 , 2020
Link: https://doi.org/10.1007/..
 
?
7

PCN163 SEQUENTIAL TREATMENT REGIMENS FOR ELDERLY PATIENTS W..:

Rochau, U. ; Vukićević, D. ; Angerer, S....
Value in Health.  22 (2019)  - p. S467 , 2019
Link: https://doi.org/10.1016/..
 
?
8

NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR..:

Ansell, S. ; Ramchandren, R. ; Domingo‐Domènech, E....
Hematological Oncology.  37 (2019)  S2 - p. 146-147 , 2019
Link: https://doi.org/10.1002/..
 
?
9

SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH ..:

Nowakowski, G. ; Willenbacher, W. ; Greil, R....
Hematological Oncology.  37 (2019)  S2 - p. 132-134 , 2019
Link: https://doi.org/10.1002/..
 
?
10

Evaluating results from the multiple myeloma patient subset..:

Raje, N ; Vadhan-Raj, S ; Willenbacher, W...
Blood Cancer Journal.  6 (2016)  1 - p. e378-e378 , 2016
Link: https://doi.org/10.1038/..
 
?
11

Comparative Effectiveness of Treatment Strategies For Multi..:

Buchberger, M ; Rochau, U ; Vukicevic, D...
Value in Health.  19 (2016)  7 - p. A710 , 2016
Link: https://doi.org/10.1016/..
 
?
12

Overview on Epidemiological Data For Multiple Myeloma In Au..:

Rochau, U ; Mühlberger, N ; Qerimi, V...
Value in Health.  19 (2016)  7 - p. A579 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Outcome of first salvage therapy for multiple myeloma (MM) ..:

Mohty, M. ; Terpos, E. ; Mateos, M.-V....
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. e274-e275 , 2015
Link: https://doi.org/10.1016/..
 
?
14

TREATMENT STRATEGIES FOR ELDERLY PATIENTS WITH NEWLY DIAGNO..:

Buchberger, M ; Rochau, U ; Vukicevic, D..
Value in Health.  18 (2015)  7 - p. A432 , 2015
Link: https://doi.org/10.1016/..
 
?
15

3219 90Y-ibritumomab-tiuxetan consolidation for advanced st..:

Mondello, P. ; Steiner, N. ; Cuzzocrea, S....
European Journal of Cancer.  51 (2015)  - p. S655 , 2015
Link: https://doi.org/10.1016/..
 
1-15